Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$328.13+3.37 (+1.04%)

Close on Nov 13, 2026Market cap $9.16BP/E –Yield –

Praxis Precision Medicines ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Praxis Precision Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Praxis Precision Medicines's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Nov 29, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRAX.

Revenue growth-100.0% · median -93.5%

Advertisement
300 × 250

See a number that looks wrong?